
IBM · NYSE
IBM sells enterprise technology and services, with software and hybrid-cloud offerings, consulting and implementation, infrastructure and transaction-processing systems, and newer AI and quantum-computing products. Software and cloud services provide recurring enterprise revenue, consulting monetizes implementation and advisory work, while infrastructure and mainframe-related systems serve mission-critical workloads. Its customers are large corporations, governments, and other institutions that require secure, continuously available computing and data systems. IBM generated $67.5 billion of revenue and $10.6 billion of net income in FY2025, compared with $62.8 billion and $6.0 billion, respectively, in FY2024.
IBM fell $1.78, or 0.76%, over the week, from $233.87 to $232.09. Trading was uneven: the stock dropped to $231.40 on September 1, stabilized on September 2, then recovered to $234.71 on September 3 and $234.89 on September 4 before giving back the entire rebound in the final session. The September 8 decline of $2.80 was the largest daily move in the supplied week. The evidence does not identify a company-specific announcement, earnings release, guidance change, or attributable analyst action during this period. Several supplied articles discuss IBM’s AI, quantum, Red Hat, and transaction-processing themes, but their publication dates and direct influence on this week’s trading are not established. Market-wide context is also not provided.
IBM fell 1.71%, from $238.79 to $234.71, with the decline concentrated early in the week before a late recovery. Shares dropped to $233.87 on Monday and $231.40 on Tuesday, then stabilized at $231.70 Wednesday and rebounded 1.30% Thursday. No company-specific announcement in the supplied evidence explains the move. Instead, trading occurred against broader concerns about AI pressure on IBM’s legacy services, cautious estimates, and an ETF outflow alert that specifically included IBM. The stock’s Thursday recovery followed coverage noting IBM had beaten the broader market’s upswing, but it did not reverse the earlier losses.
IBM fell $0.09, or 0.04%, over the week, from $235.68 to $235.59, despite substantial volatility. The stock dropped 1.97% Monday, recovered 1.36% Tuesday, fell another 1.84% Wednesday, surged 3.88% Thursday, and gave back 1.34% Friday. The largest identifiable driver was Thursday’s broad technology rally after Nvidia earnings, when the Nasdaq 100 rose 1.43%; IBM’s gain occurred alongside that market move rather than after a disclosed IBM earnings or guidance event. IBM-specific coverage focused on its dual-architecture Arm mainframe processor and quantum-computing milestone, but the supplied evidence does not establish that either directly drove trading. Options activity and ETF outflow coverage provided no clear directional catalyst.
IBM rose 4.42%, from $226.31 to $236.31, with most of the advance concentrated in Tuesday’s 3.9% jump to $235.15. The move followed coverage of IBM’s enterprise-AI relationship with OpenAI, although several reports noted the stock could still fall despite the partnership, indicating that enthusiasm was not uniform. Attention later shifted to IBM’s $240 million Together AI agreement to build an Nvidia-powered neocloud cluster, reinforcing the company’s AI-infrastructure narrative. Shares added modestly on Wednesday, gave back 1.1% Thursday, then rebounded 1.6% Friday before easing 0.4% on August 10. No earnings or guidance event was supplied; the week’s identifiable catalysts were AI partnerships and infrastructure expansion.
IBM rose 3.34% over the week, from $227.55 to $235.15. The shares initially weakened, falling from $227.55 on July 28 to $221.74 on July 30, before recovering to $223.65 on July 31 and then rallying sharply on August 3-4. The main catalyst was the post-second-quarter earnings reaction: investors looked past a top-line revenue miss and focused on AI momentum and margin expansion. Coverage also highlighted hybrid-cloud demand, Red Hat momentum, and IBM’s AI consulting backlog, while the sovereign-AI partnership with India’s Sarvam provided an additional growth narrative. No evidence indicates a material company-specific reversal after Tuesday’s rally; the week ended at its high.